+1 347 708 0418
Chronic Obstructive Pulmonary Disease (COPD) Treatment market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Chronic Obstructive Pulmonary Disease (COPD) Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
Corticosteroids
Phosphodiesterase Type 4 Inhibitors
Bronchodilators
Others
Segment by Application
Hospital
Clinic
Retail Pharmacies
Other
By Company
AstraZeneca
Boehringer Ingelheim International GmbH
GlaxoSmithKline
Novartis AG
Teva Pharmaceutical Industries
Sunovion Pharmaceuticals
CHIESI Farmaceutici
Orion Corporation
?Mylan
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
1 Report Business Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
1.2.2 Corticosteroids
1.2.3 Phosphodiesterase Type 4 Inhibitors
1.2.4 Bronchodilators
1.2.5 Others
1.3 Market by Application
1.3.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Retail Pharmacies
1.3.5 Other
1.4 Study Objectives
1.5 Years Considered
2 Global Growth Trends
2.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Perspective (2017-2028)
2.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Growth Trends by Region
2.2.1 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region: 2017 VS 2021 VS 2028
2.2.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Historic Market Size by Region (2017-2022)
2.2.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecasted Market Size by Region (2023-2028)
2.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Dynamics
2.3.1 Chronic Obstructive Pulmonary Disease (COPD) Treatment Industry Trends
2.3.2 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Drivers
2.3.3 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Challenges
2.3.4 Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Chronic Obstructive Pulmonary Disease (COPD) Treatment Players by Revenue
3.1.1 Global Top Chronic Obstructive Pulmonary Disease (COPD) Treatment Players by Revenue (2017-2022)
3.1.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Share by Players (2017-2022)
3.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue
3.4 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Concentration Ratio
3.4.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue in 2021
3.5 Chronic Obstructive Pulmonary Disease (COPD) Treatment Key Players Head office and Area Served
3.6 Key Players Chronic Obstructive Pulmonary Disease (COPD) Treatment Product Solution and Service
3.7 Date of Enter into Chronic Obstructive Pulmonary Disease (COPD) Treatment Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Chronic Obstructive Pulmonary Disease (COPD) Treatment Breakdown Data by Type
4.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Historic Market Size by Type (2017-2022)
4.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecasted Market Size by Type (2023-2028)
5 Chronic Obstructive Pulmonary Disease (COPD) Treatment Breakdown Data by Application
5.1 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Historic Market Size by Application (2017-2022)
5.2 Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecasted Market Size by Application (2023-2028)
6 North America
6.1 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2017-2028)
6.2 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
6.2.1 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2017-2022)
6.2.2 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2023-2028)
6.2.3 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Type (2017-2028)
6.3 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application
6.3.1 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2017-2022)
6.3.2 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2023-2028)
6.3.3 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Application (2017-2028)
6.4 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country
6.4.1 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2017-2022)
6.4.2 North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2023-2028)
6.4.3 U.S.
6.4.4 Canada
7 Europe
7.1 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2017-2028)
7.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
7.2.1 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2017-2022)
7.2.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2023-2028)
7.2.3 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Type (2017-2028)
7.3 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application
7.3.1 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2017-2022)
7.3.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2023-2028)
7.3.3 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Application (2017-2028)
7.4 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country
7.4.1 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2017-2022)
7.4.2 Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2023-2028)
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia
7.4.8 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2017-2028)
8.2 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
8.2.1 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2017-2022)
8.2.2 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2023-2028)
8.2.3 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Type (2017-2028)
8.3 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application
8.3.1 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2017-2022)
8.3.2 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2023-2028)
8.3.3 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Application (2017-2028)
8.4 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region
8.4.1 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region (2017-2022)
8.4.2 Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region (2023-2028)
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 Southeast Asia
8.4.7 India
8.4.8 Australia
9 Latin America
9.1 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2017-2028)
9.2 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
9.2.1 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2017-2022)
9.2.2 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2023-2028)
9.2.3 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Type (2017-2028)
9.3 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application
9.3.1 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2017-2022)
9.3.2 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2023-2028)
9.3.3 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Application (2017-2028)
9.4 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country
9.4.1 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2017-2022)
9.4.2 Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2023-2028)
9.4.3 Mexico
9.4.4 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (2017-2028)
10.2 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type
10.2.1 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2017-2022)
10.2.2 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2023-2028)
10.2.3 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Type (2017-2028)
10.3 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application
10.3.1 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2017-2022)
10.3.2 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2023-2028)
10.3.3 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Application (2017-2028)
10.4 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country
10.4.1 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2017-2022)
10.4.2 Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2023-2028)
10.4.3 Turkey
10.4.4 Saudi Arabia
10.4.5 UAE
11 Key Players Profiles
11.1 AstraZeneca
11.1.1 AstraZeneca Company Details
11.1.2 AstraZeneca Business Overview
11.1.3 AstraZeneca Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
11.1.4 AstraZeneca Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2017-2022)
11.1.5 AstraZeneca Recent Developments
11.2 Boehringer Ingelheim International GmbH
11.2.1 Boehringer Ingelheim International GmbH Company Details
11.2.2 Boehringer Ingelheim International GmbH Business Overview
11.2.3 Boehringer Ingelheim International GmbH Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
11.2.4 Boehringer Ingelheim International GmbH Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2017-2022)
11.2.5 Boehringer Ingelheim International GmbH Recent Developments
11.3 GlaxoSmithKline
11.3.1 GlaxoSmithKline Company Details
11.3.2 GlaxoSmithKline Business Overview
11.3.3 GlaxoSmithKline Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
11.3.4 GlaxoSmithKline Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2017-2022)
11.3.5 GlaxoSmithKline Recent Developments
11.4 Novartis AG
11.4.1 Novartis AG Company Details
11.4.2 Novartis AG Business Overview
11.4.3 Novartis AG Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
11.4.4 Novartis AG Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2017-2022)
11.4.5 Novartis AG Recent Developments
11.5 Teva Pharmaceutical Industries
11.5.1 Teva Pharmaceutical Industries Company Details
11.5.2 Teva Pharmaceutical Industries Business Overview
11.5.3 Teva Pharmaceutical Industries Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
11.5.4 Teva Pharmaceutical Industries Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2017-2022)
11.5.5 Teva Pharmaceutical Industries Recent Developments
11.6 Sunovion Pharmaceuticals
11.6.1 Sunovion Pharmaceuticals Company Details
11.6.2 Sunovion Pharmaceuticals Business Overview
11.6.3 Sunovion Pharmaceuticals Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
11.6.4 Sunovion Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2017-2022)
11.6.5 Sunovion Pharmaceuticals Recent Developments
11.7 CHIESI Farmaceutici
11.7.1 CHIESI Farmaceutici Company Details
11.7.2 CHIESI Farmaceutici Business Overview
11.7.3 CHIESI Farmaceutici Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
11.7.4 CHIESI Farmaceutici Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2017-2022)
11.7.5 CHIESI Farmaceutici Recent Developments
11.8 Orion Corporation
11.8.1 Orion Corporation Company Details
11.8.2 Orion Corporation Business Overview
11.8.3 Orion Corporation Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
11.8.4 Orion Corporation Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2017-2022)
11.8.5 Orion Corporation Recent Developments
11.9 ?Mylan
11.9.1 ?Mylan Company Details
11.9.2 ?Mylan Business Overview
11.9.3 ?Mylan Chronic Obstructive Pulmonary Disease (COPD) Treatment Introduction
11.9.4 ?Mylan Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2017-2022)
11.9.5 ?Mylan Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth Rate by Type (US$ Million), 2017 VS 2021 VS 2028
Table 2. Key Players of Corticosteroids
Table 3. Key Players of Phosphodiesterase Type 4 Inhibitors
Table 4. Key Players of Bronchodilators
Table 5. Key Players of Others
Table 6. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Growth Rate by Application (US$ Million), 2017 VS 2021 VS 2028
Table 7. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Region (2017-2022)
Table 10. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Region (2023-2028)
Table 12. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Trends
Table 13. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Drivers
Table 14. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Challenges
Table 15. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Restraints
Table 16. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Share by Players (2017-2022)
Table 18. Global Top Chronic Obstructive Pulmonary Disease (COPD) Treatment by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment as of 2021)
Table 19. Ranking of Global Top Chronic Obstructive Pulmonary Disease (COPD) Treatment Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Chronic Obstructive Pulmonary Disease (COPD) Treatment Product Solution and Service
Table 23. Date of Enter into Chronic Obstructive Pulmonary Disease (COPD) Treatment Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Share by Type (2017-2022)
Table 27. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Market Share by Type (2023-2028)
Table 29. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Share by Application (2017-2022)
Table 31. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue Share by Application (2023-2028)
Table 33. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 34. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 35. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 36. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 37. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 38. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 39. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 40. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 41. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 42. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 43. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 44. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 45. Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 46. Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 47. Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 48. Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 49. Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region (2017-2022) & (US$ Million)
Table 50. Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Region (2023-2028) & (US$ Million)
Table 51. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 52. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 53. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 54. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 55. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 56. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 57. Middle East and Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2017-2022) & (US$ Million)
Table 58. Middle East and Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Type (2023-2028) & (US$ Million)
Table 59. Middle East and Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2017-2022) & (US$ Million)
Table 60. Middle East and Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Application (2023-2028) & (US$ Million)
Table 61. Middle East and Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2017-2022) & (US$ Million)
Table 62. Middle East and Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size by Country (2023-2028) & (US$ Million)
Table 63. AstraZeneca Company Details
Table 64. AstraZeneca Business Overview
Table 65. AstraZeneca Chronic Obstructive Pulmonary Disease (COPD) Treatment Product
Table 66. AstraZeneca Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2017-2022) & (US$ Million)
Table 67. AstraZeneca Recent Developments
Table 68. Boehringer Ingelheim International GmbH Company Details
Table 69. Boehringer Ingelheim International GmbH Business Overview
Table 70. Boehringer Ingelheim International GmbH Chronic Obstructive Pulmonary Disease (COPD) Treatment Product
Table 71. Boehringer Ingelheim International GmbH Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2017-2022) & (US$ Million)
Table 72. Boehringer Ingelheim International GmbH Recent Developments
Table 73. GlaxoSmithKline Company Details
Table 74. GlaxoSmithKline Business Overview
Table 75. GlaxoSmithKline Chronic Obstructive Pulmonary Disease (COPD) Treatment Product
Table 76. GlaxoSmithKline Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2017-2022) & (US$ Million)
Table 77. GlaxoSmithKline Recent Developments
Table 78. Novartis AG Company Details
Table 79. Novartis AG Business Overview
Table 80. Novartis AG Chronic Obstructive Pulmonary Disease (COPD) Treatment Product
Table 81. Novartis AG Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2017-2022) & (US$ Million)
Table 82. Novartis AG Recent Developments
Table 83. Teva Pharmaceutical Industries Company Details
Table 84. Teva Pharmaceutical Industries Business Overview
Table 85. Teva Pharmaceutical Industries Chronic Obstructive Pulmonary Disease (COPD) Treatment Product
Table 86. Teva Pharmaceutical Industries Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2017-2022) & (US$ Million)
Table 87. Teva Pharmaceutical Industries Recent Developments
Table 88. Sunovion Pharmaceuticals Company Details
Table 89. Sunovion Pharmaceuticals Business Overview
Table 90. Sunovion Pharmaceuticals Chronic Obstructive Pulmonary Disease (COPD) Treatment Product
Table 91. Sunovion Pharmaceuticals Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2017-2022) & (US$ Million)
Table 92. Sunovion Pharmaceuticals Recent Developments
Table 93. CHIESI Farmaceutici Company Details
Table 94. CHIESI Farmaceutici Business Overview
Table 95. CHIESI Farmaceutici Chronic Obstructive Pulmonary Disease (COPD) Treatment Product
Table 96. CHIESI Farmaceutici Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2017-2022) & (US$ Million)
Table 97. CHIESI Farmaceutici Recent Developments
Table 98. Orion Corporation Company Details
Table 99. Orion Corporation Business Overview
Table 100. Orion Corporation Chronic Obstructive Pulmonary Disease (COPD) Treatment Product
Table 101. Orion Corporation Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2017-2022) & (US$ Million)
Table 102. Orion Corporation Recent Developments
Table 103. ?Mylan Company Details
Table 104. ?Mylan Business Overview
Table 105. ?Mylan Chronic Obstructive Pulmonary Disease (COPD) Treatment Product
Table 106. ?Mylan Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2017-2022) & (US$ Million)
Table 107. ?Mylan Recent Developments
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Type: 2021 VS 2028
Figure 2. Corticosteroids Features
Figure 3. Phosphodiesterase Type 4 Inhibitors Features
Figure 4. Bronchodilators Features
Figure 5. Others Features
Figure 6. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Application: 2021 VS 2028
Figure 7. Hospital Case Studies
Figure 8. Clinic Case Studies
Figure 9. Retail Pharmacies Case Studies
Figure 10. Other Case Studies
Figure 11. Chronic Obstructive Pulmonary Disease (COPD) Treatment Report Years Considered
Figure 12. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 13. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 14. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Region: 2021 VS 2028
Figure 15. Global Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Share by Players in 2021
Figure 16. Global Top Chronic Obstructive Pulmonary Disease (COPD) Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Obstructive Pulmonary Disease (COPD) Treatment as of 2021)
Figure 17. The Top 10 and 5 Players Market Share by Chronic Obstructive Pulmonary Disease (COPD) Treatment Revenue in 2021
Figure 18. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 19. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share by Type (2017-2028)
Figure 20. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share by Application (2017-2028)
Figure 21. North America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Share by Country (2017-2028)
Figure 22. United States Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. Canada Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 25. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share by Type (2017-2028)
Figure 26. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share by Application (2017-2028)
Figure 27. Europe Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Share by Country (2017-2028)
Figure 28. Germany Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. France Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 30. U.K. Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Italy Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. Russia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Nordic Countries Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. Asia-Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 35. Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share by Type (2017-2028)
Figure 36. Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share by Application (2017-2028)
Figure 37. Asia Pacific Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Share by Region (2017-2028)
Figure 38. China Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Japan Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. South Korea Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Southeast Asia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 42. India Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Australia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 45. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share by Type (2017-2028)
Figure 46. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share by Application (2017-2028)
Figure 47. Latin America Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Share by Country (2017-2028)
Figure 48. Mexico Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 49. Brazil Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 50. Middle East & Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY (2017-2028) & (US$ Million)
Figure 51. Middle East and Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share by Type (2017-2028)
Figure 52. Middle East and Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Market Share by Application (2017-2028)
Figure 53. Middle East and Africa Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size Share by Country (2017-2028)
Figure 54. Turkey Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 55. Saudi Arabia Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 56. UAE Chronic Obstructive Pulmonary Disease (COPD) Treatment Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 57. AstraZeneca Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2017-2022)
Figure 58. Boehringer Ingelheim International GmbH Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2017-2022)
Figure 59. GlaxoSmithKline Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2017-2022)
Figure 60. Novartis AG Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2017-2022)
Figure 61. Teva Pharmaceutical Industries Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2017-2022)
Figure 62. Sunovion Pharmaceuticals Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2017-2022)
Figure 63. CHIESI Farmaceutici Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2017-2022)
Figure 64. Orion Corporation Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2017-2022)
Figure 65. ?Mylan Revenue Growth Rate in Chronic Obstructive Pulmonary Disease (COPD) Treatment Business (2017-2022)
Figure 66. Bottom-up and Top-down Approaches for This Report
Figure 67. Data Triangulation
Figure 68. Key Executives Interviewed
Buy
